Premium
Smac mimetic enables the anticancer action of BCG‐stimulated neutrophils through TNF‐α but not through TRAIL and FasL
Author(s) -
Jinesh G. Goodwin,
Chunduru Srinivas,
Kamat Ashish M.
Publication year - 2012
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1211623
Subject(s) - fas ligand , tumor necrosis factor alpha , fas receptor , mediator , immunotherapy , apoptosis , cancer research , biology , immunology , tumor microenvironment , pharmacology , immune system , programmed cell death , microbiology and biotechnology , biochemistry
Smac mimetic overcomes resistance of bladder cancer cells to BCG‐stimulated neutrophils through TNF‐α.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom